Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc. financial statements

Sionna Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 75.27M10-K
Cash and equivalentsUSD 58.45M10-Q
Total debtUSD 8.68MEODHD

Sionna Therapeutics, Inc. financials on 6ix · Sionna Therapeutics, Inc. on 6ix